U.S. mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production), By End Use, And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Type Segment
  • 1.1.2. Application Segment
  • 1.1.3. End Use Segment
• 1.2. Estimates and Forecast Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Primary Research
• 1.5. Information or Data Analysis:
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objective

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing academic & industrial interest in mRNA technology
    • 3.2.1.2. Advantages of mRNA vaccines
    • 3.2.1.3. Increasing funding for mRNA research
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Nonexistence of effective government regulations for mRNA-based product approvals
    • 3.2.2.2. High cost of mRNA synthesis raw materials
  • 3.2.3. Market Challenge Analysis
    • 3.2.3.1. Lack of long-lasting and affordable manufacturing processes
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Type Business Analysis

• 4.1. Type Segment Dashboard
• 4.2. U.S. mRNA Synthesis Raw Materials Market Type Movement Analysis
• 4.3. U.S. mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. Capping Agents
  • 4.4.1. Capping agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. CleanCap Reagents
    • 4.4.2.1. CleanCap reagents market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. ARCA (Anti-Reverse Cap Analog)
    • 4.4.3.1. ARCA (anti-reverse cap analog) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Nucleotides
  • 4.5.1. Nucleotides market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Modified Nucleic Acids
    • 4.5.2.1. Modified nucleic acids market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2.2. N1-methylpseudouridine-triphosphate
      • 4.5.2.2.1. N1-methylpseudouridine-triphosphate market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2.3. 5-Methylcytidine triphosphate (5mCTP)
      • 4.5.2.3.1. 5-Methylcytidine triphosphate (5mCTP) market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2.4. Others
      • 4.5.2.4.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Natural Nucleic Acids
    • 4.5.3.1. Natural nucleic acids market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.2. Adenine
      • 4.5.3.2.1. Adenine market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.3. Guanine
      • 4.5.3.3.1. Guanine market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.4. Cytosine
      • 4.5.3.4.1. Cytosine market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.5. Uracil
      • 4.5.3.5.1. Uracil market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. Plasmid DNA
  • 4.6.1. Plasmid DNA market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.7. Enzymes
  • 4.7.1. Enzymes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.2. Polymerase
    • 4.7.2.1. Polymerase market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.3. RNase Inhibitor
    • 4.7.3.1. RNase inhibitor market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.4. DNase
    • 4.7.4.1. DNase market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.5. Others
    • 4.7.5.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.8. Others
  • 4.8.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. U.S. mRNA Synthesis Raw Materials Market Application Movement Analysis
• 5.3. U.S. mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Therapeutics Production
  • 5.4.1. Therapeutics production market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Vaccine Production
  • 5.5.1. Vaccine production market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Other Application
  • 5.6.1. Other application market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

• 6.1. End Use Segment Dashboard
• 6.2. U.S. mRNA Synthesis Raw Materials Market End Use Movement Analysis
• 6.3. U.S. mRNA Synthesis Raw Materials Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Biopharmaceutical & Pharmaceutical Companies
  • 6.4.1. Biopharmaceutical & pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. CROs & CMOs
  • 6.5.1. CROs & CMOs market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Academic & Research Institutes
  • 6.6.1. Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. F. Hoffmann-La Roche Ltd.
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Jena Bioscience GmbH
    • 7.4.2.1. Overview
    • 7.4.2.2. Product Benchmarking
    • 7.4.2.3. Strategic Initiatives
  • 7.4.3. Merck KGaA
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Yeasen Biotechnology (Shanghai) Co., Ltd
    • 7.4.4.1. Overview
    • 7.4.4.2. Product Benchmarking
    • 7.4.4.3. Strategic Initiatives
  • 7.4.5. BOC Sciences
    • 7.4.5.1. Overview
    • 7.4.5.2. Product Benchmarking
    • 7.4.5.3. Strategic Initiatives
  • 7.4.6. Thermo Fisher Scientific, Inc.
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Maravai LifeSciences
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. New England Biolabs
    • 7.4.8.1. Overview
    • 7.4.8.2. Product Benchmarking
    • 7.4.8.3. Strategic Initiatives
  • 7.4.9. Creative Biogene
    • 7.4.9.1. Overview
    • 7.4.9.2. Product Benchmarking
    • 7.4.9.3. Strategic Initiatives
  • 7.4.10. HONGENE
    • 7.4.10.1. Overview
    • 7.4.10.2. Product Benchmarking
    • 7.4.10.3. Strategic Initiatives
  • 7.4.11. Evonik Industries AG
    • 7.4.11.1. Overview
    • 7.4.11.2. Financial Performance
    • 7.4.11.3. Product Benchmarking
    • 7.4.11.4. Strategic Initiatives
  • 7.4.12. GENEVANT SCIENCES CORPORATION
    • 7.4.12.1. Overview
    • 7.4.12.2. Product Benchmarking
    • 7.4.12.3. Strategic Initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. mRNA synthesis raw materials market, by type, 2021 - 2033 (USD Million)
• Table 4 U.S. mRNA synthesis raw materials market, by application, 2021 - 2033 (USD Million)
• Table 5 U.S. mRNA synthesis raw materials market, by end use, 2021 - 2033 (USD Million)
• Table 6 Key companies undergoing expansions.
• Table 7 Key companies undergoing acquisitions.
• Table 8 Key companies undergoing collaborations.
• Table 9 Key companies launching new products/services.
• Table 10 Key companies undertaking other strategies.

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 U.S. mRNA synthesis raw materials market: market outlook
• Fig. 7 U.S. mRNA synthesis raw materials competitive insights
• Fig. 8 Parent market outlook
• Fig. 9 U.S. mRNA synthesis raw materials market driver impact
• Fig. 10 U.S. mRNA synthesis raw materials market restraint impact: Type & services movement analysis
• Fig. 11 U.S. mRNA synthesis raw materials market: Type outlook and key takeaways
• Fig. 12 Capping agents market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 13 CleanCap reagents market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 14 ARCA (anti-reverse cap analog) market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 15 Others market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 16 Nucleotides market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 17 Modified nucleic acids market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 18 N1-methylpseudouridine-triphosphate market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 19 5-Methylcytidine triphosphate (5mCTP) market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 20 Others market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 21 Natural nucleic acids market estimates and forecasts,2021 - 2033 (USD Million)
• Fig. 22 Adenine market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 23 Guanine market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Cytosine market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 25 Uracil market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 26 Plasmid DNA market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 27 Enzymes market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 28 Polymerase market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 29 RNase inhibitor market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 30 DNase materials market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 31 Others market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 32 Others market estimates and forecasts,2021 - 2033 (USD Million)
• Fig. 33 U.S. mRNA synthesis raw materials market: Application movement analysis
• Fig. 34 U.S. mRNA synthesis raw materials market: Application outlook and key takeaways
• Fig. 35 Vaccine production market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 36 Therapeutics production market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 37 Other application market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 38 U.S. mRNA synthesis raw materials market: End Use movement analysis
• Fig. 39 U.S. mRNA synthesis raw materials market: End Use outlook and key takeaways
• Fig. 40 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 41 Biopharmaceutical & pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 42 CROs CMOs market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 43 Market share of key market players - U.S. mRNA synthesis raw materials market